Literature DB >> 9862379

Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels.

F Bovia1, A C Nabili-Tehrani, C Werner-Favre, M Barnet, V Kindler, R H Zubler.   

Abstract

The anti-apoptotic proteins bcl-2 and bcl-xL seem to exhibit strictly opposite expression patterns in normal lymphoid cell differentiation stages, with bcl-2 low and bxl-xL high in immature and mature proliferating cells, the reverse being the case in recirculating quiescent cells. However, it is in fact not known whether recirculating memory cells are bcl-xL low or high. We analyzed memory (immunoglobulin isotype-switched) B cells in human peripheral blood, which were small lymphocytes in the G0 phase of the cell cycle, but proliferated better than naive B cells in response to Staphylococcus aureus Cowan I. Ex vivo these cells co-expressed bcl-2 together with bcl-xL mRNA and protein at high levels. The mcl-1 mRNA level was low. The bcl-xL mRNA level decreased during culture in medium containing fetal calf serum, which implies that it is maintained in vivo by continuous or frequent, non-mitogenic signal(s). The high bcl-xL expression of memory B cells may be relevant with regard to their longevity and/or their capacity to undergo an accelerated secondary type immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862379     DOI: 10.1002/(SICI)1521-4141(199812)28:12<4418::AID-IMMU4418>3.0.CO;2-7

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Naive and memory B cells in T-cell-dependent and T-independent responses.

Authors:  R H Zubler
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  Naïve and memory B cells exhibit distinct biochemical responses following BCR engagement.

Authors:  Leen Moens; Alisa Kane; Stuart G Tangye
Journal:  Immunol Cell Biol       Date:  2016-04-22       Impact factor: 5.126

3.  Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice.

Authors:  Chen-Feng Qi; Dong-Mi Shin; Zhaoyang Li; Hongsheng Wang; Jianxum Feng; Janet W Hartley; Torgny N Fredrickson; Alexander L Kovalchuk; Herbert C Morse
Journal:  J Pathol       Date:  2010-05       Impact factor: 7.996

4.  Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.

Authors:  Kichul Ko; Jianing Wang; Stuart Perper; Yulei Jiang; Denisse Yanez; Natalya Kaverina; Junting Ai; Vladimir M Liarski; Anthony Chang; Yahui Peng; Li Lan; Susan Westmoreland; Lisa Olson; Maryellen L Giger; Li Chun Wang; Marcus R Clark
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

5.  Bcl-x(L) expression in vivo in rheumatoid synovium.

Authors:  S Busteed; M W Bennett; C Molloy; A Houston; M A Stone; F Shanahan; M G Molloy; J O'Connell
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

6.  Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection.

Authors:  K Titanji; A Nilsson; C Mörch; A Samuelsson; A Sönnerborg; S Grutzmeier; M Zazzi; A De Milito
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 7.  Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.

Authors:  Jeremy F Brooks; Janet M Davies; James W Wells; Raymond J Steptoe
Journal:  J Mol Med (Berl)       Date:  2017-11-17       Impact factor: 4.599

8.  Repression of BCL-6 is required for the formation of human memory B cells in vitro.

Authors:  Tracy C Kuo; Arthur L Shaffer; Joseph Haddad; Yong Sung Choi; Louis M Staudt; Kathryn Calame
Journal:  J Exp Med       Date:  2007-04-02       Impact factor: 14.307

9.  Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.

Authors:  Agnieszka Szymula; Richard D Palermo; Amr Bayoumy; Ian J Groves; Mohammed Ba Abdullah; Beth Holder; Robert E White
Journal:  PLoS Pathog       Date:  2018-02-20       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.